GlassScriptPhysician profile
Earle C Grey
NPI 1104982628
$2,257.54
in general payments reported to CMS, 2019-2025
22 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $245 · 2022: $298 · 2023: $611 · 2024: $741 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,715.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $617.24 | 2021-2025 | Centerpiece Plate Fixation System, Mazor X System, Cd Horizon Spinal System |
| Smith+Nephew, INC. | $283.44 | 2023-2024 | Pico 14, Renasys Touch, Pico |
| Coastal Medical Technologies LLC | $280.96 | 2023-2024 | |
| Boston Scientific Corporation | $170.89 | 2024 | |
| Globus Medical, INC. | $155.85 | 2021-2023 | Elsa, Elsa Al/Atp, Rise-L . Rise-L A/L, Sable |
| Baxter Healthcare | $143.48 | 2023-2025 | Floseal |
| Mimedx Group, INC. | $139.63 | 2024 | |
| Carlsmed, INC. | $65.05 | 2024 | Aprevo |
| Life Spine, INC. | $62.46 | 2022 | |
| Stryker Corporation | $59.62 | 2022-2025 | Target |
| Relievant Medsystems, INC. | $57.89 | 2021-2023 | Intracept |
| Ethicon US, LLC | $57.24 | 2022-2024 | Surgiflo Hemostatic Matrix |
| Convatec INC. | $21.71 | 2021 | |
| Monteris Medical Corporation | $21.67 | 2021 | |
| Integra Lifesciences Corporation | $20.29 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $16.55 | 2023 | Bonescalpel |
| Alexion Pharmaceuticals, INC. | $16.39 | 2022 | |
| Si-Bone, INC. | $16.38 | 2025 | |
| Arteriocyte Medical Systems, INC. | $14.84 | 2023 | Magellan |
| Lemaitre Vascular, INC. | $14.74 | 2025 | Anastoclip Gc 8cm (Medium) |
| Sanara Medtech INC. | $12.82 | 2023 | Celleraterx |
| Orthofix Medical, INC. | $8.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Earle Grey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.